Clincosm LogoSign in Get a demo

Chronic Graft Versus Host Disease

Showing 26 - 33 of 33
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic GVHD Trial in United States (Ixazomib Citrate, Laboratory Biomarker Analysis, Quality-of-Life Assessment)

Completed
Has Results
  • Chronic Graft Versus Host Disease
  • Ixazomib Citrate
  • +3 more
  • Tampa, Florida
  • +5 more
Jan 15, 2019

Chronic GVHD Trial in Worldwide (ENTO, Placebo)

Terminated
Has Results
  • Chronic Graft Versus Host Disease
  • Miami, Florida
  • +29 more
Dec 5, 2018

Chronic GVHD Trial in United States (Ponesimod)

Terminated
Has Results
  • Chronic Graft Versus Host Disease
  • Scottsdale, Arizona
  • +9 more
Apr 9, 2018

Bronchiolitis Obliterans, Chronic GVHD, Leukotriene Trial run by the NCI (Singulair (Montelukast Sodium))

Completed
Has Results
  • Bronchiolitis Obliterans
  • +4 more
  • Singulair (Montelukast Sodium)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 6, 2018

Chronic GVHD Trial in Caen (PET (18-FDG))

Unknown status
  • Chronic Graft Versus Host Disease
  • PET (18-FDG)
  • Caen, France
    University Hospital
Jan 31, 2017

Chronic GVHD Trial in Boston (bortezomib, Prednisone)

Completed
Has Results
  • Chronic Graft Versus Host Disease
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jun 29, 2015

Chronic GVHD Trial in Rochester (PET-CT Scan)

Terminated
  • Chronic Graft Versus Host Disease
  • PET-CT Scan
  • Rochester, New York
    University of Rochester Medical Center
Oct 14, 2013

Chronic GVHD Trial in Hangzhou (Biological: mesenchymal stem cell, Cyclosporine and Glucocorticoid)

Unknown status
  • Chronic Graft Versus Host Disease
  • Biological: mesenchymal stem cell
  • Cyclosporine and Glucocorticoid
  • Hangzhou, Zhejiang, China
    Zhejiang University
Aug 1, 2012